Decreased Jun-D and myogenin expression in muscle wasting of human cachexia
1 Department of Surgery, 2 Department of Medicine, 3 Moores Cancer Center, 4 General Clinical Research Center, and 5 Biostatistics and Bioinformatics, University of California San Diego; and 6 Veterans Affairs Healthcare System, San Diego, California Submitted 22 June 2008 ; accepted in final form 1...
Saved in:
Published in | American journal of physiology: endocrinology and metabolism Vol. 297; no. 2; pp. E392 - E401 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
American Physiological Society
01.08.2009
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 1 Department of Surgery, 2 Department of Medicine, 3 Moores Cancer Center, 4 General Clinical Research Center, and 5 Biostatistics and Bioinformatics, University of California San Diego; and 6 Veterans Affairs Healthcare System, San Diego, California
Submitted 22 June 2008
; accepted in final form 17 May 2009
Muscle wasting is a critical feature of patients afflicted by acquired immune deficiency syndrome (AIDS), cancer, or chronic inflammatory diseases. In a mouse model of muscle wasting, TNF- induces oxidative stress and nitric oxide synthase-2 (NOS2) and decreases myogenin, Jun-D, and creatinine kinase muscle isoform (CKM) expression. Here, we studied 12 patients with muscle wasting due to cancer ( N = 10) or AIDS ( N = 2) and 4 control subjects. We show that in skeletal muscle of cachectic patients there is 1 ) increased expression and activity of the TNF- signaling, including TNF- mRNA, activation of TNFR1, and TNF- -associated to TNFR1; 2 ) increased oxidative stress, as determined by the presence of malondialdehyde-lysine adducts; 3 ) increased NOS2 mRNA and protein; 4 ) decreased expression of Jun-D, myogenin, myosin, and CKM mRNA and protein; 5 ) impaired CKM-E box binding activities, associated with decreased Jun-D/myogenin activities; and 6 ) oxidative modification and ubiquitination of Jun-D. These studies show that these molecular pathways are modulated in association with muscle wasting in patients with cancer or AIDS, and whether or not they cause muscle wasting remains to be determined.
muscle atrophy; creatinine kinase; nitric oxide synthase-2; Ref-1
Address for reprint requests and other correspondence: M. Buck, VAMC, 9-111-D, 3350 La Jolla Village Dr., San Diego, CA 92161 (e-mail: mbuck{at}ucsd.edu ) |
---|---|
Bibliography: | SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 Address for reprint requests and other correspondence: M. Buck, VAMC, 9-111-D, 3350 La Jolla Village Dr., San Diego, CA 92161 (e-mail: mbuck@ucsd.edu) |
ISSN: | 0193-1849 1522-1555 1522-1555 |
DOI: | 10.1152/ajpendo.90529.2008 |